Cargando…

p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets

The key tumor suppressor protein p53, additionally known as p53, represents an attractive target for the development and management of anti-cancer therapies. p53 has been implicated as a tumor suppressor protein that has multiple aspects of biological function comprising energy metabolism, cell cycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Md Ataur, Park, Moon Nyeo, Rahman, MD Hasanur, Rashid, Md Mamunur, Islam, Rokibul, Uddin, Md Jamal, Hannan, Md Abdul, Kim, Bonglee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827382/
https://www.ncbi.nlm.nih.gov/pubmed/35155422
http://dx.doi.org/10.3389/fcell.2022.761080
_version_ 1784647616424837120
author Rahman, Md Ataur
Park, Moon Nyeo
Rahman, MD Hasanur
Rashid, Md Mamunur
Islam, Rokibul
Uddin, Md Jamal
Hannan, Md Abdul
Kim, Bonglee
author_facet Rahman, Md Ataur
Park, Moon Nyeo
Rahman, MD Hasanur
Rashid, Md Mamunur
Islam, Rokibul
Uddin, Md Jamal
Hannan, Md Abdul
Kim, Bonglee
author_sort Rahman, Md Ataur
collection PubMed
description The key tumor suppressor protein p53, additionally known as p53, represents an attractive target for the development and management of anti-cancer therapies. p53 has been implicated as a tumor suppressor protein that has multiple aspects of biological function comprising energy metabolism, cell cycle arrest, apoptosis, growth and differentiation, senescence, oxidative stress, angiogenesis, and cancer biology. Autophagy, a cellular self-defense system, is an evolutionarily conserved catabolic process involved in various physiological processes that maintain cellular homeostasis. Numerous studies have found that p53 modulates autophagy, although the relationship between p53 and autophagy is relatively complex and not well understood. Recently, several experimental studies have been reported that p53 can act both an inhibitor and an activator of autophagy which depend on its cellular localization as well as its mode of action. Emerging evidences have been suggested that the dual role of p53 which suppresses and stimulates autophagy in various cencer cells. It has been found that p53 suppression and activation are important to modulate autophagy for tumor promotion and cancer treatment. On the other hand, activation of autophagy by p53 has been recommended as a protective function of p53. Therefore, elucidation of the new functions of p53 and autophagy could contribute to the development of novel therapeutic approaches in cancer biology. However, the underlying molecular mechanisms of p53 and autophagy shows reciprocal functional interaction that is a major importance for cancer treatment and manegement. Additionally, several synthetic drugs and phytochemicals have been targeted to modulate p53 signaling via regulation of autophagy pathway in cancer cells. This review emphasizes the current perspectives and the role of p53 as the main regulator of autophagy-mediated novel therapeutic approaches against cancer treatment and managements.
format Online
Article
Text
id pubmed-8827382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88273822022-02-10 p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets Rahman, Md Ataur Park, Moon Nyeo Rahman, MD Hasanur Rashid, Md Mamunur Islam, Rokibul Uddin, Md Jamal Hannan, Md Abdul Kim, Bonglee Front Cell Dev Biol Cell and Developmental Biology The key tumor suppressor protein p53, additionally known as p53, represents an attractive target for the development and management of anti-cancer therapies. p53 has been implicated as a tumor suppressor protein that has multiple aspects of biological function comprising energy metabolism, cell cycle arrest, apoptosis, growth and differentiation, senescence, oxidative stress, angiogenesis, and cancer biology. Autophagy, a cellular self-defense system, is an evolutionarily conserved catabolic process involved in various physiological processes that maintain cellular homeostasis. Numerous studies have found that p53 modulates autophagy, although the relationship between p53 and autophagy is relatively complex and not well understood. Recently, several experimental studies have been reported that p53 can act both an inhibitor and an activator of autophagy which depend on its cellular localization as well as its mode of action. Emerging evidences have been suggested that the dual role of p53 which suppresses and stimulates autophagy in various cencer cells. It has been found that p53 suppression and activation are important to modulate autophagy for tumor promotion and cancer treatment. On the other hand, activation of autophagy by p53 has been recommended as a protective function of p53. Therefore, elucidation of the new functions of p53 and autophagy could contribute to the development of novel therapeutic approaches in cancer biology. However, the underlying molecular mechanisms of p53 and autophagy shows reciprocal functional interaction that is a major importance for cancer treatment and manegement. Additionally, several synthetic drugs and phytochemicals have been targeted to modulate p53 signaling via regulation of autophagy pathway in cancer cells. This review emphasizes the current perspectives and the role of p53 as the main regulator of autophagy-mediated novel therapeutic approaches against cancer treatment and managements. Frontiers Media S.A. 2022-01-26 /pmc/articles/PMC8827382/ /pubmed/35155422 http://dx.doi.org/10.3389/fcell.2022.761080 Text en Copyright © 2022 Rahman, Park, Rahman, Rashid, Islam, Uddin, Hannan and Kim. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Rahman, Md Ataur
Park, Moon Nyeo
Rahman, MD Hasanur
Rashid, Md Mamunur
Islam, Rokibul
Uddin, Md Jamal
Hannan, Md Abdul
Kim, Bonglee
p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
title p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
title_full p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
title_fullStr p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
title_full_unstemmed p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
title_short p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
title_sort p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827382/
https://www.ncbi.nlm.nih.gov/pubmed/35155422
http://dx.doi.org/10.3389/fcell.2022.761080
work_keys_str_mv AT rahmanmdataur p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT parkmoonnyeo p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT rahmanmdhasanur p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT rashidmdmamunur p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT islamrokibul p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT uddinmdjamal p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT hannanmdabdul p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets
AT kimbonglee p53modulationofautophagysignalingincancertherapiesperspectivesmechanismandtherapeutictargets